←
SwanBio Therapeutics149 posts
SwanBio Therapeutics avatar

SwanBio Therapeutics

@SwanBioTx

Fueled by a unique company culture, we are researching & developing life-changing gene therapies for people with devastating inherited neurological conditions.

◷ Joined February 2020▧ 102 Photos and videos
SwanBio Therapeutics avatar
SwanBio Therapeutics@SwanBioTx·30 May 2023

We often hear how helpful these virtual support groups can be to families impacted by #rarediseases like #adrenomyeloneuropathy. Please check this out or pass along.

ULF@UlfUnited30 May 2023

Join us tomorow, May 31st! We will discuss ways to cope with everyday stressors that caregivers regularly face within the leukodystrophy community. The sessions are confidential and will not be recorded Register at ow.ly/13Sc50OkQ9B #ulf #leukodystrophy #notgivingup

Post attachment
Acumen avatar
⟳ SwanBio Therapeutics retweeted
Acumen@AcumenAnalytics·18 May 2023

Listen to "Being a Life Sciences Leader." It's an important conversation that goes beyond just #LifeSciences but offers a look at leadership, teamwork & company culture. Thanks @LifeSciencesPA! x.com/LifeSciencesPA/status/… #LSPA #acumen #collaborate #innovate #accelerate #transform

A new episode of Being a Life Sciences Leader is live! Tom Anderson, CEO and Director of @SwanBioTx, explains how a mentor influenced a change early on in his career and how to manage a board in a way that benefits your company. Stream the episode here: https://t.co/zNKDAGqzXj

Post attachment
SwanBio Therapeutics avatar
SwanBio Therapeutics@SwanBioTx·19 Apr 2023

Looking forward to another great event this year celebrating #Philadelphia innovators!

🎉 Get ready for the PARTY of the YEAR! Join us at the Enterprise Awards on 5/23 as we celebrate the BEST in tech, life sciences, innovation & investment! Don't miss an electrifying night of networking, delicious food, and endless inspiration! RSVP @ https://t.co/14yszED9B9

Post attachment
SwanBio Therapeutics avatar
SwanBio Therapeutics@SwanBioTx·28 Mar 2023

Deep understanding of rare neurological disease is essential for R&D of meaningful therapies. That's why we're investing in studies about the experiences of patients with adrenomyeloneuropathy (#AMN). Sharing more at #AANAM: https://t.co/8RorM4n10L